How to choose a peptide clinic: 10 questions to ask

Look for a clinic where a licensed clinician actually talks with you, reviews your health and medicines, and writes a prescription for you by name to a state-licensed pharmacy that can show the ingredient's test certificate. Under the October 2026 HHS policy, each product should hold one peptide, carry a compounded-drug label, and come with a way to report side effects.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2026-12-12.

Book my consultation Video consultations with an Aayu Well physician. Most major insurance accepted, plus convenient cash pay options.

The 10 questions

1. Who is the prescriber, and are they licensed in my state? You should be able to look the clinician up on your state licensing board's website.
2. Will someone take my history and review my medicines first? A prescription written for you by name is one of the HHS conditions, and a real evaluation should come before it.
3. Which pharmacy fills it, and is it licensed in my state? Ask for the pharmacy's name, then look it up with your state board of pharmacy.
4. Is this peptide one of the six, and is my route allowed? The policy covers BPC-157 (injection, by mouth, on the skin), TB-500 (injection), epitalon (injection, in courses with breaks between them), Semax (nasal), KPV (by mouth, on the skin) and MOTS-c (injection). For anything else, ask which rule the pharmacy relies on.
5. Can I see the certificate of analysis? The ingredient should come from an FDA-registered manufacturer, with batch testing for identity, purity, strength and contaminants.
6. Does each product contain one peptide? The policy covers single-ingredient products.
7. What will the label say? Look for "This is a compounded drug product. Not for resale." and how to report a side effect.
8. If I swallow it, how do you know it's absorbed? Peptides are hard to absorb by mouth, so the policy expects the pharmacy to show that its oral product reaches the body.
9. What comes in the box? The policy allows one device with the product: an FDA-cleared syringe.
10. Who do I call if I have a side effect? You should be able to reach a clinician, and the pharmacy reports serious side effects to FDA's MedWatch program.

Answers worth a second look

• "You don't need to talk to anyone. Just fill out the form."
• "It's research grade, so it's purer."
• "We combine several peptides so you get more benefits."
• "We can't share the certificate."
• Promises of specific results, or pressure to pay for several months up front.

What good care feels like

The best version of these ten answers sounds the same whatever you're treated for: a physician who takes the time to listen, looks at your whole health, checks every medicine you take, and stays reachable after the visit.

That's how we work at Aayu Well. Your obesity medicine physician sees you by video, a registered dietitian helps with food, and your care team is a message away between visits. We focus on weight, metabolic health, sleep and mood, with medicine when it's right for you. We don't prescribe peptides right now, and we're glad to talk them through with you. Book my consultation

For the background, see which peptides can be compounded and why the research-use-only label matters.

Questions people ask

Does Aayu Well prescribe peptides?

Not right now. We're reviewing the evidence and the pharmacy requirements. You can still bring your peptide questions to a visit: your physician will go over the evidence and build a plan for the goal behind them.

Can a telehealth visit be enough to prescribe a peptide?

In many states, yes, if the prescriber is licensed where you live and does a real evaluation, including your history and medicines. Rules differ by state, so ask which states the clinician is licensed in.

Are peptide blends allowed?

Not under the HHS policy, which covers products with a single peptide. A blend such as BPC-157 with TB-500 falls outside it.

What is a certificate of analysis?

A lab report for one batch of the ingredient, showing what it is, how pure and strong it is, and tests for contaminants such as endotoxins and heavy metals. Under the HHS policy it names the FDA-registered manufacturer and where it was made.

Sources

1. HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, Appendices A and B (October 2026)
2. Federal Register notice FR Doc. 2026-22192, 91 FR 68526 (October 30, 2026)
3. FDA: Human drug compounding
4. FDA MedWatch: Safety Information and Adverse Event Reporting Program